跳到主要內容

Bradbury Daniel 的 Form 4 申報

Castle Biosciences Inc(CSTL),2024/2/7 申報

申報編號
0001447362-24-000010
申報時間
2024/2/7
交易日
2024/2/5-2/6
申報延遲
2 天
10b5-1 計畫
有勾選

這份申報列了 9 筆非衍生性交易。公開市場賣出合計 $49.4 萬。交易後 2 天申報。

申報人

一份 Form 4 可以有好幾位申報人,例如本人與他控制的基金。各交易表上顯示的是第一位。

這份申報的申報人
申報人與公司的關係
Bradbury DanielCIK 0001236397董事

非衍生性證券(表 I)

普通股等股票的取得與處分,每一列是申報上的一筆。

非衍生性證券的交易
交易日證券交易股數價格金額交易後持股持有方式旗標
2024/2/5Common StockS賣出處分−2,751$22.74F2−$62,557.7461,944間接
2024/2/5Common StockS賣出處分−2,963$22.74F2−$67,378.6238,870間接
2024/2/5Common StockS賣出處分−2,964$22.74F2−$67,401.3638,885間接
2024/2/5Common StockS賣出處分−863$23.42F6−$20,211.4661,081間接
2024/2/5Common StockS賣出處分−930$23.42F6−$21,780.637,940間接
2024/2/5Common StockS賣出處分−931$23.42F6−$21,804.0237,954間接
2024/2/6Common StockS賣出處分−3,121$23.63F7−$73,749.2357,960間接
2024/2/6Common StockS賣出處分−3,362$23.63F7−$79,444.0634,578間接
2024/2/6Common StockS賣出處分−3,364$23.63F7−$79,491.3234,590間接

附註與備註

本站收錄交易價格引用的附註、修正申報(Form 4/A)的全部附註,以及申報的備註。其他附註,例如間接持有的方式、交易計畫的細節,請看 SEC EDGAR 上的原文。

F2

This transaction was executed in multiple trades at prices ranging from $22.33 to $23.32, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F6

This transaction was executed in multiple trades at prices ranging from $23.33 to $23.53, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

F7

This transaction was executed in multiple trades at prices ranging from $23.22 to $23.95, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

表 I 有 3 筆交易的價格引用這則附註。

看 SEC EDGAR 上的完整原文 (在新分頁開啟)